Read more
Psychedelic Schools for ‘Shamans’ Are Popping Up Like Mushrooms

Even before Oregon and Washington, D.C., decriminalized medical psilocybin, the active ingredient in “magic mushrooms,” in November, a market was emerging for schools that teach mental and medical health professionals how to use psychedelics in their treatment.

Read more
The public’s perception of the harms of magic mushrooms is in line with science — but not with the law

New research suggests that the public’s perception of the potential harms of magic mushrooms is not in line with drug laws.

Read more
What Will The Psychedelics Space Look Like In 2021? Experts Weigh In

In 2020, psychedelics took the world by storm. Over two dozen companies in the sector became publicly listed. 

Read more
MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD

MindMed begins the first Phase 1 clinical trial testing the safety and tolerance of MDMA and LSD in combination.

Read more
Trump Grants Clemency To Marijuana Prisoners On Last Day In Office

As one of his final acts in the White House, President Trump on Wednesday announced that he has granted clemency to dozens more people with marijuana and drug convictions.

Read more
Low Tide For Psychedelic Stocks With Media, Investors Distracted

The U.S. election has become a major political circus. With investors distracted and the media focused elsewhere, psychedelic stocks are temporarily at low tide.

Read more
CYBIN Announces Upsize to Previously Announced Bought Deal Offering

Cybin’s bought deal financing has been upsized to CAD$30 million.

Read more
France Asks for Citizen Input on Cannabis Legalization & Related Policies

France has launched a public consultation about cannabis legalization asking citizens about their views on cannabis and what government policies people would prefer, France24 reports.

Read more
Further Research into Psilocybin Opens New Doors for Treatment

NEW YORK, Jan. 7, 2021 /PRNewswire/ — Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )